[Experience with an oral corticoid-antihistaminic combination in dermatological practice].
D000293:Adolescent; D000328:Adult; D000368:Aged; D001623:Betamethasone / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D003877:Dermatitis, Contact / Q000188:drug therapy; D009783:Dermatitis, Occupational / Q000188:drug therapy; D003881:Dermatomycoses / Q000188:drug therapy; D004485:Eczema / Q000188:drug therapy; D004890:Erythema / Q000188:drug therapy; D005076:Exanthema / Q000188:drug therapy; D005260:Female; D006634:Histamine H1 Antagonists / Q000627:therapeutic use*; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D010915:Pityriasis / Q000188:drug therapy; D011537:Pruritus / Q000188:drug therapy; D011565:Psoriasis / Q000188:drug therapy; D012393:Rosacea / Q000188:drug therapy; D012871:Skin Diseases / Q000188:drug therapy*
D006634:Histamine H1 Antagonists; D001623:Betamethasone
Erfahrungen mit einer oralen Corticoid- Antihistaminicum-Kombination in der dermatologischen Praxis.